RIGHT REMEDIES Maximum Strength Diuretic
- Product NDC
- 70692-595
- Requested package NDC
- 70692-595-12
- 11-digit product format
- 706920595
- Labeler code
- 70692
- Product ID
- 70692-595_571914cc-96d4-49e1-8816-7a754b2773f2
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Pamabrom
- Dosage form
- CAPSULE, LIQUID FILLED
- Route
- ORAL
- Labeler
- Strive Pharmaceuticals Inc.
- Application
- M027
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2025-05-07
- Substance
- PAMABROM
- Active strength
- 50 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- RIGHT REMEDIES Maximum Strength Diuretic
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| PAMABROM | 50 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| UA8U0KJM72 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 832080 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2d6492e0-1c16-6e3a-e063-6294a90a2440 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 6084a4f4-5437-c9a5-caec-5361ee075a59 | Product name | 1 | 20140508 |
| 90c5639a-61b0-88d6-ddcf-21888e94869a | Product name | 1 | 20140508 |
| 9514609b-a2a9-f8ec-6ba6-3f8e5ee89877 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70692-595-12 | RIGHT REMEDIES Maximum Strength Diuretic | 120 in 1 BOTTLE | CAPSULE, LIQUID FILLED | 120 | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Menstrual Complete | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | Chain Drug Marketing Association, Inc. | 5f8f9644-48c5-4556-a0a4-7bdc9a629daa | 2026-10-29 | Warnings | M027 |
| Menstrual Pain Relief | ACETAMINOPHEN, PAMABROM, PYRILAMINE MALEATE | Chain Drug Marketing Association, Inc. | 6a945066-7714-45c0-9225-a921879f6a45 | 2026-09-29 | Warnings | M027 |
| Menstrual Relief Maximum Strength | ACETAMINOPHEN, PAMABROM, PYRILAMINE MALEATE | L.N.K. International, Inc. | 92bb5cf5-5861-4f5e-91f7-9a546563c18e | 2026-09-16 | Warnings | M027 |
| Menstrual Complete | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | WALMART INC. | d288db7e-6754-4c49-be98-f501f805fbed | 2026-09-16 | Warnings | M027 |
| Menstrual Relief Maximum Strength Multi Symptom | ACETAMINOPHEN, PAMABROM, PYRILAMINE MALEATE | Cardinal Health 110, LLC. DBA Leader | 8df6e174-8ee3-46cc-98ef-2b9a801b7b78 | 2026-09-15 | Warnings | M027 |
| Menstrual Relief Maximum Strength | ACETAMINOPHEN, PAMABROM, PYRILAMINE MALEATE | Topco Associates, LLC | 18d5deea-5ddb-4c66-9e76-2fc113653357 | 2026-09-10 | Warnings | M027 |
| Menstrual Relief | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | United Natural Foods, Inc. dba UNFI | f823e8b2-bf38-409e-8197-4ddba16d3149 | 2026-09-10 | Warnings | M027 |
| Menstrual Complete | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | L.N.K. International, Inc. | c4a28f8f-030d-4487-b74f-13998482e72d | 2026-08-18 | Warnings | M027 |
| Menstrual Relief Maximum Strength | ACETAMINOPHEN, PAMABROM, PYRILAMINE MALEATE | ARMY AND AIR FORCE EXCHANGE SERVICE | 8282cb5a-6c38-4500-93bb-461e4d65df1c | 2026-08-05 | Warnings | M027 |
| Mantra Menstrual Pain Gel strawberry | ACETAMINOPHEN, PAMABROM | MOREMED INC. | 22291ca3-04c0-4386-8001-aa9bb45d7f3b | 2026-08-05 | Warnings | M027 |
| Menstrual Complete | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | Kroger Company | e97383af-6fbe-4531-af6a-c9ea9153e438 | 2026-08-03 | Warnings | M027 |
| Midol Complete | ACETAMINOPHEN, CAFFEINE, AND PYRILAMINE MALEATE | Select Consumer Group | 3ca96ed9-d9af-dbfe-e063-6394a90a2932 | 2026-07-03 | Warnings | M027 |
| MENSTRUAL COMPLETE | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | Rite Aid Corporation | de723b85-011c-4014-82a8-e813460e3f12 | 2026-06-25 | Warnings | M027 |
| Diurex Ultimate | CAFFEINE | Kobayashi Healthcare International, Inc. | c6debbfe-6061-463f-8f17-fb240c6f1bab | 2026-06-08 | Warnings | M027 |
| Menstrual Complete | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | Topco Associates, LLC | 62f03f3c-8475-40bd-a5e4-ec9292b74785 | 2026-05-19 | Warnings | M027 |
| Menstrual Complete | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | Meijer Distribution, Inc. | 14dd377f-1d30-4991-ad29-5ed1058d4622 | 2026-05-18 | Warnings | M027 |
| Menstrual Complete | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | H E B | cf228a60-4181-420f-8cb0-3db3d14a0f46 | 2026-05-18 | Warnings | M027 |
| Menstrual Relief | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | Better Living Brands, LLC | d069487b-5856-4e3e-bc0e-5e57313c8231 | 2026-05-15 | Warnings | M027 |
| Menstrual Relief | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | CVS Pharmacy | 289ec101-c9a3-45f1-b2cd-8eaf8e580130 | 2026-05-12 | Warnings | M027 |
| PMS Relief Maximum Strength | ACETAMINOPHEN, PAMABROM, PYRILAMINE MALEATE | CVS Pharmacy | 760ee367-0625-48d7-98a7-84c69389ad3e | 2026-05-12 | Warnings | M027 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 832080 | pamabrom 50 MG Oral Capsule | PSN | 2d6492e0-1c16-6e3a-e063-6294a90a2440 | 2 |
| 832080 | pamabrom 50 MG Oral Capsule | SCD | 2d6492e0-1c16-6e3a-e063-6294a90a2440 | 2 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 70692-595-12 | 70692059512 | 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (70692-595-12) | 2025-05-07 | No | No | Current |